Abrupt withdrawal of cannabidiol (CBD) is not associated with physical withdrawal symptoms

April 15, 2020
CBDoil-epidolex-1200x750.jpg

Abrupt withdrawal of cannabidiol (CBD) is not associated with physical withdrawal symptoms

The abrupt withdrawal of CBD is not associated with physical withdrawal symptoms in healthy subjects, according to a recent clinical study.

A team of researchers from the United Kingdom and the United States assessed the occurrence of withdrawal symptoms caused by the abrupt withdrawal of CBD. The subjects in the study were healthy people who took 750 mg of herbal CBD twice daily for four weeks. Study participants either continued to receive CBD or received a placebo in weeks five and six.

The researchers did not report any serious adverse events due to the discontinuation of CBD.

They concluded that healthy subjects had no evidence of withdrawal syndrome when short-term CBD treatment was abruptly discontinued.

source: https://www.ncbi.nlm.nih.gov/pubmed

Logo Can Pharma SVG

CanPharma has a pharmaceutical wholesale permission according to §52a of the German Medicines Act, as well as a license to handle narcotics in the meaning of §3 of the German narcotics legislation. Furthermore, CanPharma has a GDP-certified quality assurance system.

MEMBER OF

OFFICES

CanPharma GmbH
Wiesbadener Str. 29,
16515 Oranienburg, Germany

 

REPRESENTATIVE OFFICES

Berlin
Rosenthaler Str. 34
10178 Berlin
Germany

Barcelona
Gran de Gràcia 15, 1-1
08012 Barcelona
Spain